Celgene | Aplastic Anemia and MDS International Foundation

Celgene

Award Year: 
2016

Celgene has long been an active and engaged Foundation partner, supporting its Patient and Family Conferences, health professional conferences and educational webinars. The global organization focuses on the discovery, development and  commercialization of biopharmaceutical products to treat cancer – such as MDS and AML – as well as other severe immune and inflammatory conditions. It is widely known for its industry-leading programs that provide patients with information, support and access to its therapies.

Leadership Award Type: